Pancreatic function of spontaneously diabetic torii rats in pre-diabetic stage

Experimental Animals

Volumn 58, Issue 4, 2009, Pages 363-374

  Matsui, Kenichi ^a   Oda, Tomohiro ^a   Nishizawa, Emiko ^a   Sano, Ryuhei ^a   Yamamoto, Hiromi ^a   Fukuda, Sumiaki ^a   Sasase, Tomohiko ^a   Miyajima, Katsuhiro ^a   Ueda, Nobuhisa ^a   Ishii, Yukihito ^a   Ohta, Takeshi ^a   Matsushita, Mutsuyoshi ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

DPP IV inhibitor; GSIS; Islet; Pre diabetes; SDT rat

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GENOMIC DNA; GLUCAGON LIKE PEPTIDE; TOLBUTAMIDE; 2 (4 (AMINO(N CYCLOBUTYL N METHYLCARBAMOYL)METHYL)CYCLOHEXYLMETHOXYMETHYL) 5 METHYLBENZOIC ACID; 2-(4-(AMINO(N-CYCLOBUTYL-N-METHYLCARBAMOYL)METHYL)CYCLOHEXYLMETHOXYMETHYL)-5-METHYLBENZOIC ACID; ANTIDIABETIC AGENT; ARGININE; BENZOIC ACID DERIVATIVE; DIAGNOSTIC AGENT; ENZYME INHIBITOR; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 (7 37); GLUCAGON-LIKE PEPTIDE 1 (7-37); INSULIN; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL ACTIVATION; CELL ISOLATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; EXPERIMENTAL RAT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS FUNCTION; PROTEIN ANALYSIS; RAT; SPONTANEOUSLY DIABETIC TORRI RAT; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; GLUCOSE TOLERANCE TEST; METABOLISM; OBESITY; ORGAN CULTURE TECHNIQUE; PANCREAS; PANCREAS ISLET; PATHOLOGY; SECRETION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANTIGENS, CD26; ARGININE; BENZOIC ACIDS; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; MALE; OBESITY; ORGAN CULTURE TECHNIQUES; PANCREAS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; TOLBUTAMIDE;

EID: 73349102183     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.58.363     Document Type: Article

References (30)

1. Apweiler, R. and Freund, P. 1993. Development of glucose intolerance in obese (fa/fa) Zucker rats. Horm. Metab. Res. 25: 521-524.
2. Burkey, B.F., Li, X., Bolognese, L., Balkan, B., Mone, M., Russell, M., Hughes, T.E., and Wang, P.R. 2005. Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats. J. Pharmacol. Exp. Ther. 315: 688-695.
3. Day, C. and Bailey, C.J. 1998. Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice. Int. J. Obes. Relat. Metab. Disord. 22: 619-623.
4. de Souza, C.J., Yu, J.H., Robinson, D.D., Ulrich, R.G., and Meglasson, M.D. 1995. Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance. Diabetes 44: 984-991.
5. Kawano, K., Hirashima, T., Mori, S., Saitoh, Y., Kurosumi, M., and Natori, T. 1992. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41: 1422-1428.
6. Kenny, A.J. 1955. Extractable glucagon of the human pancreas. J. Clin. Endocrinol. Metab. 15: 1089-1105.
7. Kimura, K., Toyota, T., Kakizaki, M., Kudo, M., Takebe, K., and Goto, Y. 1982. Impaired insulin secretion in the spontaneous diabetes rats. Tohoku. J. Exp. Med. 137: 453-459.
8. Kosaka, K. 2002. Pathogenesis of type 2 diabetes mellitus from the viewpoint of clinical epidemiology. Nippon Rinsho 60: 423-467 (in Japanese).
9. Kosaka, K., Hagura, R., and Kuzuya, T. 1977. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 26: 944-952.
10. Masuyama, T., Fuse, M., Yokoi, N., Shinohara, M., Tsujii, H., Kanazawa, M., Kanazawa, Y., Komeda, K., and Taniguchi, K. 2003. Genetic analysis for diabetes in a new rat model of nonobese type 2 diabetes, Spontaneously Diabetic Torii rat. Biochem. Biophys. Res. Commun. 304: 196-206.
11. Masuyama, T., Komeda, K., Hara, A., Noda, M., Shinohara, M., Oikawa, T., Kanazawa, Y., and Taniguchi, K. 2004. Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats. Biochem. Biophys. Res. Commun. 314: 870-877.
12. Ohta, T., Furukawa, N., Komuro, G., Yonemori, F., and Wakitani, K. 1999. JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats. Br. J. Pharmacol. 126: 1674-1680.
13. Ohta, T., Furukawa, N., Yonemori, F., and Wakitani, K. 1999. JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats. Eur. J. Pharmacol. 367: 91-99.
14. Ohta, T., Matsui, K., Miyajima, K., Sasase, T., Masuyama, T., Shoda, T., Koizumi, H., Shinohara, M., and Matsushita, M. 2007. Effect of insulin therapy on renal changes in spontaneously diabetic Torii rats. Exp.Anim. 56: 355-362.
15. Ostenson, C.G., Khan, A., Abdel-Halim, S.M., Guenifi, A., Suzuki, K., Goto, Y., and Efendic, S. 1993. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia 36: 3-8.
16. Pickavance, L.C. and Wilding, J.P. 2007. Effects of S 15511, a therapeutic metabolite of the insulin-sensitizing agent S 15261, in the Zucker Diabetic Fatty rat. Diabetes Obes. Metab. 9: 114-120.
17. Poitout, V. and Robertson, R.P. 2002. Minireview: secondary beta-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology 143: 339-342.
18. Prentki, M., Joly, E., El-Assaad, W., and Roduit, R. 2002. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes 51: S405-413.
19. Robertson, R.P., Harmon, J., Tran, P.O., Tanaka, Y., and Takahashi, H. 2003. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52: 581-587.
20. Sasase, T., Ohta, T., Ogawa, N., Miyajima, K., Ito, M., Yamamoto, H., Morinaga, H., and Matsushita, M. 2006. Preventive effects of glycaemic control on ocular complications of Spontaneously Diabetic Torii rat. Diabetes Obes. Metab. 8: 501-507.
21. Sasase, T., Yamada, H., Sakoda, K., Imagawa, N., Abe, T., Ito, M., Sagawa, S., Tanaka, M., and Matsushita, M. 2005. Novel protein kinase C-beta isoform selective inhibitor JTT-010 ameliorates both hyper- and hypoalgesia in streptozotocin- induced diabetic rats. Diabetes Obes. Metab. 7: 586-594.
22. Shibata, T., Matsui, K., Nagao, K., Shinkai, H., Yonemori, F., and Wakitani, K. 1999. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative. Eur. J. Pharmacol. 364: 211-219.
23. Shibata, T., Matsui, K., Yonemori, F., and Wakitani, K. 1998. JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models. Br. J. Pharmacol. 125: 1744-1750.
24. Shinohara, M., Masuyama, T., Shoda, T., Takahashi, T., Katsuda, Y., Komeda, K., Kuroki, M., Kakehashi, A., and Kanazawa, Y. 2000. A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int. J. Exp. Diabetes Res. 1: 89-100.
25. Sudre, B., Broqua, P., White, R.B., Ashworth, D., Evans, D.M., Haigh, R., Junien, J.L., and Aubert, M.L. 2002. Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats. Diabetes 51: 1461-1469.
26. Tokuyama, Y., Sturis, J., DePaoli, A.M., Takeda, J., Stoffel, M., Tang, J., Sun, X., Polonsky, K.S., and Bell, G.I. 1995. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44: 1447-1457.
27. Unger, R.H. 1995. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44: 863-870.
28. Unger, R.H. 2002. Lipotoxic diseases. Annu.Rev. Med. 53: 319-336.
29. Unger, R.H. and Grundy, S. 1985. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28: 119-121.
30. Unger, R.H. and Zhou, Y.T. 2001. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 50: S118-121.